These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2759840)

  • 1. Cyclosporin-A treatment for early insulin-dependent diabetes mellitus: first experience in Israel.
    Kisch ES; Yust I
    Isr J Med Sci; 1989 Jul; 25(7):414-6. PubMed ID: 2759840
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine trials in diabetes: updated results of the French experience.
    Assan R; Feutren G; Sirmai J
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):178-83. PubMed ID: 3289203
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials.
    Feutren G
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):356-66. PubMed ID: 3381298
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of immunosuppression with cyclosporine in insulin-dependent diabetes mellitus of recent onset: the Canadian open study at 44 months.
    Dupré J; Stiller CR; Gent M; Donner A; von Graffenreid B; Murphy G; Heinrichs D; Jenner MR; Keown PA; Laupacis A
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):184-92. PubMed ID: 3289204
    [No Abstract]   [Full Text] [Related]  

  • 5. [On C-peptide and some other parameters in children with insulin dependent diabetes mellitus (author's transl)].
    Koepp P; Kühnau J
    Monatsschr Kinderheilkd; 1982 Apr; 130(4):215-7. PubMed ID: 7048078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression in autoimmune disease: the double-edged sword.
    Jaworski MA; Jewell LD; Honore L; Mehta JG; Bayens-Simmonds J; McGuire-Clark P; Schouls JJ; Yap WY
    Clin Invest Med; 1987 Sep; 10(5):488-95. PubMed ID: 3315371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of cyclosporin A (CsA) in insulin-dependent diabetes in children and analysis of the secondary effects].
    Lévy-Marchal C; Tubiana-Rufi N; Czernichow P
    Journ Annu Diabetol Hotel Dieu; 1987; ():187-97. PubMed ID: 3613364
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of an experimental animal controlled long-term study of cyclosporin A in diabetes mellitus type 1].
    Gardell C; Gardell D
    Beitr Infusionther Klin Ernahr; 1987; 18():393-5. PubMed ID: 3440000
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cyclosporin as treatment for insulin dependent diabetes mellitus].
    Yust I; Merdler S; Kisch E
    Harefuah; 1988 Jan; 114(2):93-4. PubMed ID: 3350421
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine, in combination with other drugs, studied in insulin-dependent diabetes therapy.
    Raymond CA
    JAMA; 1988 Mar; 259(11):1609, 1613-4. PubMed ID: 3343762
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trials of cyclosporin in IDDM.
    Dupré J; Stiller CR; Gent M; Donner A; von Graffenried B; Heinrichs D; Jenner M; Keown P; Mahon J; Martell R
    Diabetes Care; 1988; 11 Suppl 1():37-44. PubMed ID: 3069390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes, cyclosporin nephrotoxicity, and serum creatinine concentration.
    McNally PG; Feehally J; Walls J
    Diabet Med; 1991 Apr; 8(3):289. PubMed ID: 1828751
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine for treatment of early type I diabetes: preliminary results.
    Stiller CR; Laupacis A; Dupre J; Jenner MR; Keown PA; Rodger W; Wolfe BM
    N Engl J Med; 1983 May; 308(20):1226-7. PubMed ID: 6341839
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporin in diabetes.
    Koivisto VA; Pelkonen R
    Lancet; 1985 Feb; 1(8425):401. PubMed ID: 2857455
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors predictive of cyclosporine-induced nephrotoxicity: the role of cyclosporine blood levels.
    Bach JF; Feutren G; Noel LH; Hannedouche T; Landais P; Timsit J; Boitard C; Bougnères P; Boitard C; Grünfeld JP
    Transplant Proc; 1990 Jun; 22(3):1296-8. PubMed ID: 2349690
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of two periods with intensified insulin treatment on B-cell function during the first 18 months of type 1 (insulin-dependent) diabetes mellitus.
    Krarup T; Madsbad S
    Diabete Metab; 1986 Oct; 12(5):256-60. PubMed ID: 3542618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin.
    Bougnères PF; Landais P; Boisson C; Carel JC; Frament N; Boitard C; Chaussain JL; Bach JF
    Diabetes; 1990 Oct; 39(10):1264-72. PubMed ID: 2210078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pancreatic reserve in diabetes mellitus by the determination of serum C-peptide using radioimmunoassay].
    Arteaga A; Velasco N; Szegedi AM; Pellegrino MR; López G; Foradori A; Acosta AM
    Rev Med Chil; 1984 Apr; 112(4):321-9. PubMed ID: 6385178
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of C-peptide in the classification of diabetes mellitus.
    Wright-Pascoe R; Mills J; Choo-Kang E; Morrison EY
    West Indian Med J; 2000 Jun; 49(2):138-42. PubMed ID: 10948853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclosporin A and diabetes type I].
    Timsit J; Boitard C; Warnet A
    Rev Infirm; 1988 Feb; 38(3):27-30. PubMed ID: 3153531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.